Potential Immunomodulating Activity Of Neem (Azadirachta Indica) Leaf Extracts And Its Bioactive Compound N-Acetylglucosamine In Mice by Kumar, Venugopalan Santhosh
 
POTENTIAL IMMUNOMODULATING 
ACTIVITY OF NEEM (AZADIRACHTA INDICA) 
LEAF EXTRACTS AND ITS BIOACTIVE 
































ACTIVITY OF NEEM (AZADIRACHTA INDICA) 
LEAF EXTRACTS AND ITS BIOACTIVE 






























Thesis submitted in fulfillment of the requirement  
for the degree of 




































To His Holiness Melmaruvathur Arulthiru Amma and family 
And 
To my Parents Mr. M. Venugopalan 
(Retired Higher Secondary School Head Master) 
Mrs. N. Balagujambal 








I would like to express my deepest gratitude to my supervisor, Professor Emeritus 
Dr. V. Navaratnam, for his guidance, encouragement and patience throughout the 
course of this work. Professor Dr. V. Navaratnam, who has the attitude and substance 
of a genius, he continually and convincingly conveyed a spirit of adventure in regard 
to research. 
I would like to express my sincere gratitude to Professor Dr. Vicknasingam 
Balasingam Kasinather, Director, Centre for Drug Research, Universiti Sains 
Malaysia (USM), Penang, Malaysia for giving me the opportunity to carry out this 
study in the Centre for Drug Research, Universiti Sains Malaysia (USM). I am 
extremely thankful to Prof. Vicknasingam for his excellent and timely advice, 
patience, motivation and immense knowledge. Prof. Vicknasingam is a generous and 
kind personality. 
Special thanks to Professor Dr. Sharif Mahsufi Mansor for the continuous support 
of my Ph.D. study. Very special thanks to Professor Dr. Surash Ramanathan for 
the continuous support of my Ph.D. study. His guidance helped me in all the time of 
research.  
I am most grateful and enormously indebted to my co-supervisor Professor             
Dr. Rajasekaran, Principal, KMCH College of Pharmacy, Coimbatore, Tamilnadu, 
India for his enthusiasm and continuous support in this project.  
My sincere thanks are expressed to Professor N.K. Nair for his support and guidance 




I would like to thank the Institute of Post Graduate studies (IPS), Universiti Sains 
Malaysia (USM), Penang, Malaysia. 
I would like to thank the management and administration of Universiti Sains 
Malaysia (USM), Penang, Malaysia. 
I would like to thank Professor Dato’ M.S. Lye, Universiti Putra Malaysia (UPM), 
Malaysia for his encouragement in my research work. 
I am grateful to Professor Dr. Narasimhan, Chairman, Asthagiri Herbal Research 
Foundation, Chennai for his valuable suggestions in the analytical studies. I would 
like to thank Ms. Priya for her assistance in the analytical studies. 
I would like to thank the management and administration of Vels University 
(VISTAS), Chennai, India. 
Special thanks to Dr. P. Shanmugasundaram, Director, School of Pharmaceutical 
Sciences, Vels University (VISTAS), Chennai, India. 
Sincere thanks to Dr. S. Sivasubramanian, Advisor – Research & Development / 
Chairman, Centre for Advanced Research and Development (CARD), Vels 
University (VISTAS), Chennai, India & Former Vice-Chancellor, Bharathiyar 
University, Coimbatore, India and  Noorul Islam University, Kanyakumari, India. 
Special thanks to Dr. V. Ravichandran, Director, National Institute of 
Pharmaceutical Education and Research (NIPER Kolkata), Department of 
Pharmaceuticals, Ministry of Chemicals and Fertilizers, Government of India. 
Very special thanks to Dr. T. Shanmugarajan, Dr. Sowmyalakshmi 
School of Pharmaceutical Sciences, Vels University (VISTAS), Chennai.  
 
iv 
Special thanks to Dr. Sathish Kumar, Dean i/c, Academic Research,                     
Vels University.  
Dr. Sadasivan Pillai, Dr. Nagarjun, Dr. Malarkodi, Dr. Suchithra, Dr. Balaji, 
Dr.Arul, Dr.Hari, Dr.Ramachandran, Dr.Arivukarasu, Ms.Hemaand 
Mr.Rajesh for providing laboratory facilities for conducting the studies. 
Special thanks to staffs of School of Pharmaceutical Sciences, Vels University 
(VISTAS), Chennai, India. 
I would like to thank Sophisticated Analytical Instrument Facility (SAIF), Indian 
Institute of Technology (IIT), Chennai, India. 
I would like to thank the Laboratory Animal Medicine (LAM) Unit, Tamilnadu 
Veterinary and Animal Sciences University (TANUVAS), Chennai, India. 
Special thanks to my brother Mr. V. Suresh Kumar for his support and 
encouragement in my research. 
I would like to thank Dr. G. A. Shanmugasundaram for his valuable suggestions in 
Journal Publications. 
I am most grateful and enormously indebted to my wife G.A. Geetha Hari Priya 
and family members for their love, support and encouragement.  
Special thanks to all laboratory technicians. I would like to thank everyone who was 
important for the successful completion of my research work. 




TABLE OF CONTENTS 
 
 
ACKNOWLEDGEMENT  ii  
TABLE OF CONTENTS  v 
LIST OF TABLES   xiii  
LIST OF FIGURES   xv 
LIST OF PLATES   xviii 
LIST OF ABBREVIATIONS & SYMBOLS xxi 
ABSTRAK    xxv 
ABSTRACT    xxvii 
 
CHAPTER 1: INTRODUCTION 1 
 
1.1 Background of study  1 
 1.1.1 Neem tree plant sources  2 
 1.1.2  Local names of neem 4 
1.2       Literature review  5 
 1.2.1 Neem in human health 6 
  1.2.1(a) First aid 6 
  1.2.1(b) Antibacterial activity 7 
  1.2.1(c) Antiviral 8 
  1.2.1(d) Antifungal 9 
  1.2.1(e) Sexually transmitted diseases 9 
  1.2.1(f) Neem and the immune system 10 
  1.2.1(g) Anticarcinogenic activity 14 
  1.2.1(h) Antifertility 16 
  1.2.1(i) Skin diseases 18 
  1.2.1(j) Antisnake venom activity 18 
  1.2.1(k) Circulatory disorders 19 
  1.2.1(l) Digestive disorders 19 
  1.2.1(m) Nervous disorders 21 





           1.2.2 Neem in animal health 22 
1.3 Neem tree    23 
 1.3.1 Parts of Neem  23 
 1.3.2 Chemical constituents 24 
                        1.3.2(a) Isoprenoids – diterpenoids 24 
                        1.3.2(b) Triterpenoids 25 
                        1.3.2(c) Protomeliacins 26 
                        1.3.2(d) Limonoids with intact four rings  
                                      γ-hydroxybutenolide side chain 28 
                        1.3.2(e) Gedunin 29 
                        1.3.2(f) Azadirone 30 
                        1.3.2(g) C-Secomeliacins 30 
1.4 Overview of the immune system 37 
 1.4.1 Mitochondria  37 
 1.4.2 Thymus    38 
 1.4.3 Spleen    39 
1.4.4 Cytokines       40 
1.4.5 Interleukin-2       40 
1.4.6 Dexamethasone      42 
1.4.7 Withanolide A      43 
1.5 Adverse events of genetically engineered interleukin-2 43 
1.6       Problem statements  44 
1.7 Research objectives of the study 46 
1.8 Flow diagram of the study 48 
 
CHAPTER 2: MATERIALS AND METHODS 49 
 
2.1      Research materials   49 
           2.1.1  List of chemicals 49 
           2.1.2  List of equipments and instruments    51 
2.2 Collection and authentication of plant 51 
2.3 Preparation of A. indica leaves extracts  
 by soxhlet method                                                                          52 
 2.3.1 Preparation of hexane, chloroform, methanol and  
            water extracts of A. indica leaves 52 
 
vii 
2.4 Preparation of A. indica leaves extracts by  52 
 cold extraction      
 2.4.1 Preparation of hexane, chloroform, methanol and  52 
                        water extracts of A. indica leaves  
2.5  Experimental animals                                                                         53 
2.6  Thin layer chromatography (TLC) of A. indica 53 
 leaves soxhlet and cold extracts 
 2.6.1 Separation of phytoconstitutents of hexane  54 
  soxhlet extract of A. indica leaves by TLC  
 2.6.2   Separation of phytoconstitutents of chloroform  54 
  soxhlet extract of A. indica leaves by TLC    
 2.6.3 Separation of phytoconstitutents of methanol  54 
  soxhlet extract of A. indica leaves by TLC   
 2.6.4 Separation of phytoconstitutents of aqueous 54 
  soxhlet extract of A. indica leaves by TLC   
 2.6.5 Separation of phytoconstitutents of hexane  54 
  cold extract of A. indica leaves by TLC   
 2.6.6 Separation of phytoconstitutents of chloroform  55 
  cold extract of A. indica leaves by TLC   
 2.6.7 Separation of phytoconstitutents of methanol  55 
  cold extract of A. indica leaves by TLC   
 2.6.8 Separation of phytoconstitutents of aqueous 55 
  cold extract of A. indica leaves TLC   
2.7  Preliminary pharmacological screening of                55 
soxhlet and cold extracts of A. indica leaves 
 2.7.1 Preliminary pharmacological screening  55 
 2.7.2 Anaesthetic used in the preliminary pharmacological  57 
  screening    
2.8 Mouse IL-2 ELISA kit (Thermo Scientific) 58 
 2.8.1  Materials used  58 
 2.8.2  Sample (serum) preparation 58 
 2.8.3  Reagent preparation 59 




  2.8.3(b) Anti-IL-2-HRP Conjugate Concentrate  59 
     for the preparation of Conjugate reagent  
 2.8.4 Standard preparation 59 
 2.8.5 Standard dilution 59 
 2.8.6  Storage   60 
 2.8.7  Assay procedure 60 
 2.8.8 Calculation of Results  61 
2.9 Qualitative analysis of phytoconstituents of aqueous  61 
 extract of A. indica  leaves  
 2.9.1  Test for tannins 61 
 2.9.2  Test for phlobatannins 61 
 2.9.3  Test for saponins 62 
 2.9.4  Test for flavonoids 62 
 2.9.5  Test for terpenoids 62 
 2.9.6  Test for cardiac glycosides 62 
 2.9.7  Test for Reducing Sugars 63 
  2.9.7(a) Fehling’s Test 63 
  2.9.7(b) Benedicts Test 63 
2.10 Column chromatography (CC)     63 
 2.10.1 Sample handling 64 
 2.10.2 Fractionation  64 
2.11 TLC of the mixed fractions (17, 18, 19 and 20) of aqueous  64 
            extract of A. indica leaves 
2.12 High performance liquid chromatography (HPLC) 65 
2.13 Fourier transform-infrared spectroscopy (FT-IR)     65 
2.14     Isolation and characterization of A. indica leaves compound 65 
2.15 Analytical study of the isolated A. indica leaves compound    66 
2.16 Nuclear magnetic resonance spectroscopy  66 
            (1H ,13C-NMR and 2DNMR – COSY, HSQC)  
 2.16.1  Software and hardware 66 
 2.16.2  Probes    67 
                       2.16.2(a)  Broadband gradient probe head 5mm; 'BBO' , 67 
                                       with VT and auto tune 
                       2.16.2(b)  Quadrupole inverse probe with gradient 67 
 
ix 
 2.16.3  NMR sample procedure 67 
2.17 Acute toxicity study   68 
            2.17.1 Experimental setup for acute toxicity study 68 
2.18 Evaluation of immunostimulant activity of               69 
N-Acetylglucosamine (NAG) 
 2.18.1  Experimental Setup  69 
  2.18.1(a) Anaesthetic used  in the pharmacological studies 70 
 2.18.2 Introduction of Mouse IL-2 ELISA kit (Ray Bio) 71 
 2.18.3 Reagents   71 
 2.18.4 Storage   72 
 2.18.5 Materials used  72 
 2.18.6 Reagent preparation 72 
 2.18.7 Assay procedure 73 
 2.18.8 Calculation of results 74 
2.19 Histopathology          74 
2.20 Evaluation of NAG on murine lymphocytes                74 
2.21 Murine splenocytes preparation     75 
2.22 Statistical analysis                   76 
2.23 Immunohistochemistry (IHC) study 76 
 2.23.1 Preparation and staining of frozen tissue sections  77 
 2.23.2 Sectioning of frozen tissues     78 
 2.23.3 Standard immunochemical staining procedures   78 
  for frozen sections     
 2.23.4 Secondary Antibody (Biotin Rat Anti-Mouse (CD25) 80 
2.24      Mitochondrial studies                 80 
 2.24.1 Effect of NAG on mitochondrial perturbations provoked   80 
  by dexamethasone in mice thymocytes 
  2.24.1(a)Animals and treatment    80 
  2.24.1(b)Experimental setup                80 
 2.24.2 Isolation of mitochondria     82 
            2.24.3 Estimation of mitochondrial protein    82 
 2.24.4 Estimation of mitochondrial markers     83 




2.24.4(b) Assay of α-ketoglutarate dehydrogenase   84 
 (α-KDH)  
  2.24.4(c) Assay of isocitratedehydrogenae (ICDH)  85 
  2.24.4(d) Assay of succinate dehydrogenase (SDH)             85 
 2.24.5 Estimation of mitocondrial  antioxidant system  86 
  2.24.5(a)Assay of glutathione peroxidase (GPx)  86 
  2.24.5(b) Assay of glutathione-S-transferase (GST)   86 
  2.24.5(c) Assay of superoxide dismutase (SOD)  87 
  2.24.5(d) Assay of glutathione (GSH)         87 
 2.24.6 Estimation of  lipid peroxides    88 
 2.24.7 Estimation of ATP        88  
2.25 Transmission electron microscopy (TEM)    89 
2.26 Histopathological studies      89 
2.27 Statistical analysis                   89 
CHAPTER 3: RESULTS        90 
3.1  Yield of A. indica leaves soxhlet and cold extracts 90 
 3.1.1  Yield of crude A. indica leaves soxhlet extracts 90 
 3.1.2  Yield of crudeA. indica leaves cold extracts 90 
 3.1.3 Yield of aqueous extract of A. indica leaves, mixed  91 
  fractions and  NAG 
3.2  Thin layer chromatography (TLC) of crude soxhlet and  92 
 cold extracts of  A. indica leaves  
3.3  Preliminary pharmacological screening of soxhlet and  94 
 cold extracts of A. indica leaves  
3.4 Thin layer chromatography (TLC) of aqueous crude   95 
 cold extract of A. indica leaves  
3.5 Qualitative analysis of phytoconstitutents of aqueous  98 
 extract of A. indica  leaves fractions 17, 18, 19 and 20  
3.6 TLC of the column chromatography fractions of aqueous  99 
 extract of A. indica leaves  
3.7 TLC of the column chromatography mixed fractions  102 





3.8 Isolation and characterization of A. indica leaves compound 103 
3.8.1    Preliminary analytical study of aqueous extract of A. indica 
            leaves by GC-MS     105 
3.8.2    Preliminary analytical study of aqueous extract of A. indica  
            leaves by LC-MS     106 
3.8.3   Analytical study of A. indica leaves compound by GC-MS  108 
3.8.4   Analytical study of A. indica leaves compound by proton,  110 
           carbon NMR and 2D NMR (COSY, HSQC) 
3.9 Acute toxicity study  118 
3.10 Evaluation of immunostimulant activity of NAG   120 
3.11 Effect of NAG on organs weight 121 
3.12 Effect of NAG on body weight level 123 
3.13 Histopathological study 124 
3.14 Effect ofNAG on murine lymphocytes    131 
3.15 Effects of NAG on spleen organ weight    132  
3.16 Immunohistochemistry of NAGon IL-2 receptor in               133 
 mice thymus 
3.17 Mitochondrial studies in thymus of mice    135 
     3.17.1  Estimation of mitochondrial protein    135 
 3.17.2 Effect of NAG and WA on mitochondrial markers  136 
 3.17.3 Effect of NAG and WA on mitochondrial    138 
  enzymatic antioxidants 
 3.17.4 Effect of NAG and WA on mitochondrial GSH in   144 
  thymus of mice 
 3.17.5 Effect of NAG and WA on mitochondrial LPO in   146 
  thymus of mice 
 3.17.6 Effect of NAG and WA on mitochondrial ATP  148 
3.18 Ultra structural mitochondrial study of amelioration of   150 
 NAG on thymic perturbations provoked by dexamethasone  
 in mice thymocytes 
3.19 Ultra structural nucleus study of amelioration of NAG on              154 
 thymic perturbations provoked by dexamethasone in  




3.20 Histopathological study of amelioration of NAG on thymic            158 
 perturbations provoked by dexamethasone in mice thymocytes 
3.21 Mechanism of action of NAG               165 
 
CHAPTER 4: DISCUSSION AND CONCLUSIONS 167 
4.1  Discussion     167 
4.2  Conclusion     181 
 
CHAPTER 5: RECOMMENDATION FOR FUTURE RESEARCH 182 
 
REFERENCES     183 
APPENDICES      





LIST OF TABLES 
 
  Page 
Table 1.1 Taxonomic position of A. indica 3 
Table 1.2 Local names of neem 4 
Table 1.3 Medicinal uses of neem 6 
Table 2.1 List of chemicals and manufacturers 49 
Table 2.2 List of equipments and manufacturers 51 
Table 2.3 Experimental setup of preliminary pharmacological 
screening 
56 
Table 2.4 Anaesthetic used in the preliminary pharmacological 
screening 
57 
Table 2.5 Materials used in mouse IL-2 ELISA 58 
Table 2.6 Experimental setup of acute toxicity studies 69 
Table 2.7 Experimental setup of immunostimulant activity of NAG 70 
Table 2.8 Anaesthetic used in the pharmacological studies 71 
Table 2.9 Components used in mouse IL-2 ELISA 71 
Table 2.10 Materials used in mouse IL-2 ELISA 72 
Table 2.11 Experimental setup of NAG effect on murine 
lymphocytes 
75 
Table 2.12 Experimental setup of immunohistochemistry studies 77 
Table 2.13 Experimental setup of mitochondrial studies 81 
Table 3.1 Yield of crude A. indica leaves soxhlet extracts using 
respective solvents 
90 
Table 3.2 Yield of crude A. indica leaves cold extracts using 
respective solvents 
91 
Table 3.3 Yield of aqueous extract of A. indica leaves, mixed 




  Page 
Table 3.4 TLC of crude soxhlet and cold extracts of A. indica leaves 93 
Table 3.5 TLC of aqueous crude cold extract of A. indica leaves 96 
Table 3.6 Qualitative analysis on phytochemical constituents of 
aqueous extract A. indica leaves fractions 17, 18, 19 and 
20 
98 
Table 3.7 TLC of the column chromatography fractions of aqueous 
extract of A. indica leaves  
100 
Table 3.8 Chromatographic parameters 104 
Table 3.9 Comparative study of the molecular weight of the 
reported A. indica leaves compounds with GC-MS 
chromatogram of the aqueous extract of A. indica leaves 
106 
Table 3.10 Comparative study of the molecular weight of the 
reported    A. indica leaves compounds with LC-MS 
chromatogram of the aqueous extract of A. indica leaves 
108 
Table 3.11 NMR interpretation of the isolated aqueous A. indica 
leaves compound 
114 










LIST OF FIGURES 
 
  Page 
Figure 1.1 Neem Tree 3 
Figure 1.2 Sugiol 24 
Figure 1.3 Nimbiol 25 
Figure 1.4 Margocin 25 
Figure 1.5 Meliantriol 26 
Figure 1.6 Nimbocinone 27 
Figure 1.7 Nimolinone 27 
Figure 1.8 Kulactone 28 
Figure 1.9 Nimocinolide 28 
Figure 1.10 Isonimocinolide 29 
Figure 1.11 Gedunin 29 
Figure 1.12 Azadirone 30 
Figure 1.13 Nimbin 31 
Figure 1.14 Salannin 31 
Figure 1.15 Azadirachtin 32 
Figure 1.16 Deacetylnimbinene 33 
Figure 1.17 Azadiradione 34 
Figure 1.18 Mahmoodin 34 
Figure 1.19 Naheedin 35 
Figure 1.20 Azadirachtol 35 
Figure 1.21 Nimbolide B 36 
 
xvi 
Figure 1.22 Nimbic acid B 36 
Figure 1.23 Inteleukin-2 structure 41 
Figure 2.1 Standard serial dilution of recombinants mouse IL – 2 60 
Figure 2.2 Standard serial dilution of recombinants mouse IL - 2 73 
Figure 3.1 Preliminary pharmacological screening of soxhlet and 
cold extracts of A. indica leaves on serum interleukin-2 
(IL-2) 
94 
Figure 3.2 Chromatogram of A. indica leaves compound by HPLC 103 
Figure 3.3 FT-IR spectra of A. indica leaves compound 104 
Figure 3.4 GC-MS chromatogram of aqueous extract of A. indica 
leaves 
105 
Figure 3.5 LC-MS chromatogram of aqueous extract of A. indica 
leaves 
107 
Figure 3.6 Analytical study spectral data of A. indica leaves 
compound by GC-MS 
109 
Figure 3.7 1H NMR spectroscopy of A. indica leaves compound 110 
Figure 3.8 13C NMR spectroscopy of A. indica leaves compound 111 
Figure 3.9 
 





2D NMR HSQC spectroscopy of A. indica leaves 
compound 
113 
Figure 3.11 Structural representation of N-Acetylglucosamine (NAG) 115 
Figure 3.12 α and β forms of N-Acetylglucosamine 115 
Figure 3.13 Effect of NAG on serum IL-2 level of mice 120 
Figure 3.14 Effect of NAG on thymus 121 
Figure 3.15 Effect of NAG on liver 122 
Figure 3.16 Effect of NAG on kidney 122 
 
xvii 
Figure 3.17 Effect of NAG on body weight level 123 
Figure 3.18 Effect of NAG on lymphocytes 132 
Figure 3.19 Effect of NAG on spleen 132 
Figure 3.20 Estimation of mitochondrial protein 135 
Figure 3.21 Effect of NAG and WA on the levels of MDH, α-KDH, 
ICDH and SDH in thymus of mice 
136 
Figure 3.22 Effect of NAG and WA on the levels of GPx in thymus of 
mice 
138 
Figure 3.23 Effect of NAG and WA on the levels of GST in thymus of 
mice 
140 
Figure 3.24 Effect of NAG and WA on the levels of SOD in thymus of 
mice 
142 
Figure 3.25 Effect of NAG and WA on the levels of GSH in thymus of 
mice 
144 
Figure 3.26 Effect of NAG and WA on the levels of LPO in thymus of 
mice 
146 
Figure 3.27 Effect of NAG and WA on the levels of ATP in thymus of 
mice 
148 





LIST OF PLATES 
 
  Page 
Plate 3.1 TLC of aqueous crude cold extract of A. indica leaves at 
UV 365nm Mobile Phase - Water : Methanol (6:4) 
97 
Plate 3.2 TLC of column chromatography fractions 7-16 (UV 
365nm) of aqueous extract of A. indica leaves 
101 
Plate 3.3  TLC of column chromatography fractions 17-24 (UV 
365nm) of aqueous extract of A. indica leaves 
101 
Plate 3.4 TLC of the column chromatography fractions (17-20) of  
A. indica leaves extract at visible light, 254nm and treated 
with sulphuric acid 
102 
Plate 3.5 Control group mice thymus(100x) 125 
Plate 3.6 NAG(266µg/kg) treated mice thymus(100x) 126 
Plate 3.7 NAG(400µg/kg) treated mice thymus(100x) 126 
Plate 3.8 NAG(800µg/kg) treated mice thymus(100x) 127 
Plate 3.9 Control group mice liver(100x) 127 
Plate 3.10 NAG(266µg/kg) treated mice liver(100x) 128 
Plate 3.11 NAG(400µg/kg) treated mice liver(100x) 128 
Plate 3.12 NAG(800µg/kg) treated mice liver(100x) 129 
Plate 3.13 Control group mice kidney(100x) 129 
Plate 3.14 NAG(266µg/kg) treated mice kidney(100x) 130 
Plate 3.15 NAG(400µg/kg) treated mice kidney(100x) 130 
Plate 3.16 NAG(800µg/kg) treated mice kidney(100x) 131 
Plate 3.17 Control group mice thymus immunohistochemical staining 
of CD25 positive cells 
133 
Plate 3.18 NAG(266 µg/kg) mice thymus immunohistochemical 




  Page 
Plate 3.19 NAG(400µg/kg) mice thymus immunohistochemical 
staining of CD25 positive cells 
134 
Plate 3.20 NAG(800µg/kg) mice thymus immunohistochemical 
staining of CD25 positive cells 
134 
Plate 3.21 Control group mice thymus mitochondria TEM image 150 
Plate 3.22 Dexamethasone 5 mg/kg treated group mice thymus 
mitochondria TEM image 
151 
Plate 3.23 Dexamethasone 5 mg/kg + NAG 266µg/kg treated mice 
thymus mitochondria TEM image 
151 
Plate 3.24 Dexamethasone 5 mg/kg + NAG 400µg/kg treated mice 
thymus mitochondria TEM image 
152 
Plate 3.25 Dexamethasone 5 mg/kg + NAG 800µg/kg treated mice 
thymus mitochondria TEM image 
152 
Plate 3.26 Dexamethasone 5 mg/kg +WA 800µg/kg treated mice 
thymus mitochondria TEM image 
153 
Plate 3.27 Control group mice thymus nucleus TEM image 154 
Plate 3.28 Dexamethasone 5 mg/kg treated group mice thymus 
nucleus TEM image 
155 
Plate 3.29 Dexamethasone 5 mg/kg + NAG 266µg/kg treated mice 
thymus nucleus TEM image 
155 
Plate 3.30 Dexamethasone 5 mg/kg + NAG 400µg/kg treated mice 
thymus nucleus TEM image 
156 
Plate 3.31 Dexamethasone 5 mg/kg + NAG 800µg/kg treated mice 
thymus nucleus TEM image 
156 
Plate 3.32 Dexamethasone 5 mg/kg +WA 800µg/kg treated mice 
thymus nucleus TEM image 
157 
Plate 3.33 Control group mice thymus histopathology(100x) 159 
Plate 3.34 Control group mice thymus histopathology(400x) 159 






  Page 
Plate 3.36 Dexamethasone 5 mg/kg treated group mice thymus 
histopathology(400x) 
160 
Plate 3.37 Dexamethasone 5 mg/kg + NAG 266µg/kg treated mice 
thymus histopathology (100x) 
161 
Plate 3.38 Dexamethasone 5mg/kg + NAG 266µg/kg treated mice 
thymus histopathology(400x) 
161 
Plate 3.39 Dexamethasone 5mg/kg + NAG 400µg/kg treated mice 
thymus histopathology(100x) 
162 
Plate 3.40 Dexamethasone 5mg/kg + NAG 400µg/kg treated mice 
thymus histopathology(400x) 
162 
Plate 3.41 Dexamethasone 5mg/kg + NAG 800µg/kg treated mice 
thymus histopathology(100x) 
163 
Plate 3.42 Dexamethasone 5mg/kg + NAG 800µg/kg treated mice 
thymus histopathology(400x) 
163 
Plate 3.43 Dexamethasone 5mg/kg + WA 800µg/kg treated mice 
thymus histopathology (100x) 
164 












LIST OF ABBREVIATIONS & SYMBOLS 
 
ANOVA   Analysis of variance 
ATP                                   Adenosine triphosphate 
DEX                             Dexamethasone 
D2O    Deuterium Oxide  
DMSO    Dimethyl sulfoxide 
ED50    Effective dose 50% 
ELISA    Enzyme linked immunosorbent assay 
FDA    Food and Drug Administration 
g    Gram 
GPx             Glutathione peroxidase 
GR    Glutathione reductase 
GSH             Glutathione 
GST                                     Glutathione S-transferases 
h    Hour 
HPLC    High performance liquid chromatography 
ICDH             Isocitrate dehydrogenase 
IL-2    Interleukin-2 
i.p.    Intraperitoneal 
α- KDH            alpha ketoglutarate dehydrogenase 
L    Litre 
LD50    Lethal dose 50% 
LPO                                     Lipid peroxide 
µg    Microgram 
MDA    Malondialdehyde 
MDH            Malate dehydrogenase  
mg    Milligram 
min    Minute 
ml            Millilitre 
MnSOD     Mitochondrial antioxidant manganese superoxide  
               dismutase 
MW    Molecular Weight 
NADPH            Nicotinamide adenine dinucleotide phosphate 
 
xxii 
NAG                                     N-Acetylglucosamine 
NIAID                          National Institute of Allergy and Infectious Diseases 
NIH                                       National Institutes of Health 
NK cells   Natural killer cells 
NMR    Nuclear magnetic resonance  
O-NAG            O-linked N-Acetylglucosamine  
PBS    Phosphate buffer saline 
pg             Pico Gram 
ROS             Reactive oxygen species 
ROO                                     Peroxyl radical 
Rf    Retention factor 
SD    Standard deviation 
SDH             Succinate dehydrogenase 
SOD             Superoxide dismutase 
RPM    Rotation per minute 
temp.    Temperature 
TEM                                     Transmission electron microscopy 
TLC    Thin layer chromatography 
TMB    3, 3’, 5’, 5’ – Tetramethylbenzidine 
UV    Ultra violet 
UNEP                                  United Nations Environment Programme 
WA                           Withanolide A 
wt    Weight 











POTENSI AKTIVITI IMMUNOMODULASI BAGI EKSTRAK DAUN  
NEEM (AZADIRACHTA INDICA) DAN SEBATIAN BIOAKTIFNYA  





Kajian ini bertujan untuk menilai potensi aktiviti immunostimulan dari daun 
Azadirachta indica N-Acetylglucosamine (AILG) dalam mencit. Ekstrak heksana, 
klorofom, metanol dan akueus daun A. indica telah disediakan dan aktiviti 
immunostimulan telah dikaji. Ekstrak akueus daun A. indica (AEAIL) menunjukkan 
aktiviti immuostimulan yang lebih signifikan (P<0.001) daripada lain-lain ekstrak. 
Oleh itu pengasingan juzuk fito dari AEAIL telah dijalankan dan                              
N-Acetylglucosamine (NAG) telah di pencilkan. NAG telah diberikan pada 266, 400, 
800 μg / kg kepada mencit secara intraperitonial selama 4 minggu untuk menilai 
aktiviti immunostimulan. Paras serum interleukin-2 (IL-2) dan kajian 
histopatologikal pada timus telah dilakukan untuk mengesahkan aktiviti 
immunostimulan (NAG). Pemberian NAG dalam dos seperti di atas meningkatkan 
serum IL-2 secara signifikan (P<0.001) dalam mencit ujian berbanding mencit 
kawalan. Kesan pergantungan dos bagi IL-2 telah diperhati dalam mencit yang 
dirawat dengan NAG. Berat timus, hati dan buah pinggang meningkat secara 
signifikan (P<0.001) dari minggu kedua ke minggu keempat berbanding mencit 
kawalan. Percambahan T-limfosit dalam timus selepas pemberian NAG diperhatikan 
dalam kajian histopatologikal. Kesan NAG dan withanolide A (WA - kawalan 
positif) pada penanda mitokondria, sistem antioksida, perubahan ultrastruktur dalam 
mitokondria, nukleus dan kajian histopatologi telah dijalankan dalam mencit teraruh 
deksametason (DEX). Pendedahan kepada DEX  mengurangkan paras penanda 
mitokondria, enzim antioksida, adenosina trifosfat (ATP) dan peningkatan paras lipid 
 
xxiv 
peroksida (LPO) berbanding kumpulan, kawalan. Rawatan dengan NAG (266, 400, 
800 μg / kg) dan WA (800 μg / kg) menunjukkan bahawa terdapat peningkatan yang 
ketara dalam paras penanda mitokondria dan enzim antioksida, ATP dan paras LPO 
menurun berbanding kumpulan yang dirawat dengan DEX. Kajian mikroskop 
transmisi elektron (TEM) mendedahkan bahawa  kumpulan yang dirawat dengan 
DEX menunjukkan perubahan yang  merosakkan kristae mitokondria dan nukleus 
bengkak piknotik manakala kumpulan yang dirawat dengkan NAG menunjukkan 
penyusunan semula pembentukan kristae mitokondria dan nukleus. Kajian 
histopatologi menunjukkan bahawa kumpulan timus tikus yang dirawat dengkan 
NAG menunjukkan percambahan timosit berbanding kumpulan kawalan. Mekanisme 
yang munasabah mengenai NAG boleh dikaitkan dengan membaik pulih enzim 
mitokondria maka dengan itu meningkatkan pengeluaran tenaga mitokondria yang 

















POTENTIAL IMMUNOMODULATING ACTIVITY OF NEEM 
(AZADIRACHTA INDICA) LEAF EXTRACTS AND ITS BIOACTIVE 




Present study was aimed to evaluate the potential immunostimulant activity of N-
Acetylglucosamine (NAG) from Azadirachta indica leaves in mice. The hexane, 
chloroform, methanol and aqueous extracts of A. indica leaves were prepared and its 
immunostimulant activity was studied. The aqueous extract of A. indica leaves 
(AEAIL) showed significant (P< 0.001) higher immunostimulant activity than other 
extracts. Hence, isolation of possible phytoconstituent(s) from AEAIL was carried 
out and the N-Acetylglucosamine (NAG) was isolated. The NAG was administered 
at 266, 400 and 800 µg/kg of mice, intraperitoneal route weekly for 4 weeks to 
evaluate immunostimulant activity. The serum interleukin-2 (IL-2) level and 
histopathological studies on thymus were performed to confirm NAG 
immunostimulant activity. The administration of above doses of NAG has 
significantly (P< 0.001) increased serum IL-2 levels in mice than control mice. The 
dose dependent effect on IL-2 was noticed in NAG treated mice. The weight of 
thymus, liver and kidney were significantly (P< 0.001) increased after the NAG 
treatments compared to control mice. Also, body weight of NAG treated mice 
showed significant (P< 0.001) increment from second week to fourth week than 
control mice. The proliferation of T-lymphocytes in thymus after the administration 
of NAG was observed in histopathological study. Effect of NAG and withanolide A 
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(WA - positive control) on mitochondrial markers, antioxidant system, ultrastructural 
changes in mitochondria, nucleus and histopathological studies were performed in 
dexamethasone induced thymus of mice. Exposure to dexamethasone (DEX) leads to 
decreased level of mitochondrial markers, enzymatic antioxidants, adenosine 
triphosphate (ATP) and increased level of lipid peroxide (LPO) when compared to 
control group. Treatment with NAG (266, 400, 800 µg/kg) and WA (800 µg/kg) 
showed that there was a significant increase in the levels of mitochondrial markers 
and enzymatic antioxidants, ATP and decreased level of LPO when compared to 
DEX treated group. Transmission electron microscopy (TEM) studies revealed that 
DEX treated group shows destructive alterations of mitochondrial cristae and 
pyknotic swollen nucleus whereas NAG treated group shows the restructuring of the 
formation of cristae of mitochondria and nucleus. Histopathological studies showed 
that NAG treated group mice thymus shows proliferation of thymocytes when 
compared to control group. The plausible mechanism of NAG was associated with 
the restoration of mitochondrial enzymes thereby improving mitochondrial energy 






1.1 Background of study 
The United Nations Environment Programme announced neem as a "Tree of the 21st 
century". In 1992 the US National Academy of Science tabled a report mentioning 
Neem as the tree for solving global problems”. Immunosupression is a decrease in 
immune function measured as an effect on cellular, humoral, or non-specific immune 
parameters. The likely clinical sequels of immunosupression are increased rates of 
infectious diseases and neoplasia. Clinicians agree that susceptible groups are more 
likely to suffer adverse health consequences from any immune suppression. 
The immune system and its response to stimulation can be disrupted by oxidative 
stress and this may be hugely due to underlying immune dysfunction (Sordillo and 
Aitken, 2009). The thymus is a primary lymphoid organ contributing immune 
longevity.  When there is impaired immunity, the individual suffers from increased 
susceptibility to a variety of illnesses due to dysfunction of thymocytes (Dietert and 
Zelikoff, 2010; Morris et al., 2013). It has become clear that oxidative stress is the key 
factor responsible for the onset and progression of a number of immunological 
disorders (Hybertson et al.,  2011; Daniela et al., 2009). It is also well accepted now 
that apoptosis induced by the oxidative stress in thymocytes is an imperative for 
immunosuppressive function in human and various animal species in vivo and in vitro 
(Kumar et al., 2015; Yi et al., 2016). There is clear evidence that loss of function in 
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the respiratory chain complex in mitochondria leads to apoptosis and thymocyte death 
(Ricci et al., 2003).  
Scientists are now able to mass produce immune cell secretions, both antibodies and 
lymphokines, as well as specialized immune cells. The ready supply of these materials 
not only has revolutionized the study of the immune system itself but also has had an 
enormous impact on medicine. Medicinal plants have been used as sources of 
medicine for boosting the immune system with less adverse events. They have been 
investigated for immunomodulatory potentials and it has been proved by diverse 
mechanisms in animal models that medicinal plants have beneficial effect on the 
immune system. The use of immunostimulants has opened a very promising new 
chapter in immunotherapy. Immunostimulants are used to enhance the bodys immune 
system and play a vital role to treat immune deficiencies. 
1.1.1 Neem tree plant sources 
From prehistorical times the neem tree (Azadirachta indica) has been considered a 
divine tree. It was during the Indus Valley Civilization that the first medicinal uses of 
the neem plant were recorded. Neem is considered as a blessed tree (Figure 1.1). It 
belongs to the Family Meliaceae, the mahogany family, and the botanincal name of 
neem is A. indica A. Juss (Table 1.1). The name Azadirachta indica is derived from 
the Persian language where Azad means “free”, dirakht means “tree” and i-Hind 
means “of Indian origin”. In other words, it can be called “The Free Tree of India”. 
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Figure 1.1 Neem Tree (Girish and Shankara, 2008). 
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1.1.2 Local names of neem 
Neem is native to the Indian subcontinent. The names of neem in various Indian and 
world languages are listed in Table 1.2 (Imam, Hussain and Ajij, 2012). From time 
immemorial, medicinal plants have been used for the treatment of many infectious 
diseases without any scientific evidence. At present there is more emphasis on 
determining the scientific evidence and rationalization of the use of these 
preparations.  
Table 1.2 Local names of neem  
Languages Local names of neem 
English  Neem 
German  Indischer Zadrach 
Persian  Azade Darakhte Hindi 
Malay  Pokok Semambu, Dawoon Nambu, Baypay  
Chinese Lian shu, Lian zao zi, Yin du lian shu 
Arabic  Azad Darkhtu Hind 
Thai Khwinin, Sadao India  
Burmese  Tamabin, Kamakha 
Latin  Azadirachta indica A. Juss or Melia 
azadirachta Linn 
Singapore  Nimba 
French  Azarirae d’lnde, Margousier 
Indonesia  Mimba 
Nigeria  Don goyaro 
Simhalee  Nimu 
Spanish  Margosa 
Indonesia Mimba 
Portuguese  Margosa, Nimbo 
Tamil  Vembu 
Hindi  Neem 
Marathi  Kadunimb 
Gujarati  Leemdo 
Punjabi  Nimb 
Malayalam  Veppu, Aryaveppu 
Telegu  Vepa 
Kannada  Bevinmar, Kahibevu 
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1.2 Literature review 
The neem tree (A. indica) is mainly cultivated in South East Asia. Quality assurance 
of raw materials of neem and processing of raw materials and traditional uses of neem 
were well documented (Puri, 1999). The neem tree has been used as a source of 
unique natural products for integrated pest management, medicine, industry and other 
purposes (Schmutterer, 1995). Neem root, bark and young fruit have astringent, tonic 
and antiperiodic activity. Bark is bitter, vermifuge and cures ulcers. Neem leaves have 
anthelmintic, insecticidal activity and can be used to treat skin diseases (Upma et al., 
2011). In traditional Indian medicine neem plays a major role in the treatment of 
various human diseases. Numerous biologically active compounds were present in 
neem and recognized for various pharmacological effects (Sushma, Smriti and 
Sheveta, 2012). Historical survey of indigenous drugs and the evolution of the present 
Indian indigenous drugs were documented. In the rural areas of India water extraction 
of neem leaves is used for the prophylactic and therapeutic treatment of various 
diseases. Medicinal uses of various parts of neem are listed in Table 1.3. 
Botelho et al. (2008) studied the efficacy of a neem leaves based mouth rinse. The 
aim of the study was to compare the short term efficacy and safety of a A. 
indica mouth rinse on gingival inflammation and microbial plaque, compared to 
0.12% chlorhexidine. A double - masked, randomized, parallel armed study was 
carried out to assess the efficacy of the neem leaves based oral mouthrinse in reducing 
gingivitis. 
Biswas et al. (2002) studied the biological activities and medicinal properties of neem 
and reported that neem leaf, bark, flowers, fruit, twig, gum, oil and root has been used 
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to treat leprosy, piles, cough and ring worms. Neem (A. indica) is perhaps the most 
useful traditional medicinal plant in India. Each part of the neem tree has some 
medicinal property and is thus commercially exploitable. This review gives a bird’s 
eye view mainly on the biological activities of some of the neem compounds isolated, 
pharmacological actions of the neem extracts, clinical studies and plausible medicinal 
applications of neem along with their safety evaluation. 
Table 1.3 Medicinal uses of neem (Biswas et al., 2002). 
 
Part Medicinal use 
Leaf Leprosy, eye problem, epistaxis, intestinal worms, anorexia, 
biliousness, skin ulcers. 
Bark Analgesic, alternative and curative of fever. 
Flower Bile suppression, elimination of intestinal worms and 
phlegm. 
Fruit Relieves piles, intestinal worms, urinary disorder, epistaxis, 
phlegm, eye problem, diabetes, wounds and leprosy. 
Twig Relieves cough, asthma, piles, phantom tumour, intestinal 
worms, spermatorrhoea, obstinate urinary disorder, diabetes. 
Gum Effective against diseases like ring worms, scabies, wounds 
and ulcers. 
Seed pulp Leprosy and intestinal worms. 
Oil Leprosy and intestinal worms. 
Root, bark, leaf, 
flower and fruit 
together 
Blood morbidity, biliary afflictions, itching, skin ulcer, 
burning sensation and leprosy.  
 
1.2.1 Neem in human health 
1.2.1 (a) First aid 
Neem’s antiseptic and healing properties make it an excellent first aid for minor cuts 
and abrasions, and it has been shown to be an excellent wound healer. Neem has the 
ability to increase vascular permeability by increasing the blood flow and by helping 
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the body to rapidly create collagen fibers to close wounds.There are reports from the 
National University of Singapore (Jin et al., 2013) stating that tissue engineered plant 
extracts can be used as nanofibrous wound dressings. 
1.2.1 (b) Antibacterial activity 
Anti-microbial activities of aqueous extracts from neem were reported by Wafaa, 
Hassan and Nefisa (2007). The aqueous extraction of neem leaves, seeds and seed 
hulls was carried out at 80°C under acidic, neutral and alkaline conditions. The 
sulphation of nine crude extracts was carried out using chlorosulphonic acid as 
sulfating agent in formamide. Anticoagulation and fibrinolytic activities, as well as 
antimicrobial effect of aqueous extracts and their corresponding sulphates are 
demonstrated. Native extracts and their corresponding sulfates gave various inhibition 
activities against the gram positive bacteria Staphylococcus aureus, the gram negative 
bacteria Escherichia coli, the yeasts Candida albicans, Fungi Aspergillus niger and 
Penicillium citrinum.  
Yu et al. (2010) isolated the antibacterial compound from petroleum ether extract of 
neem oil. The tetrahydrofuranyl diester from neem oil was investigated for 
antibacterial activity against three bacterial strains viz., S. aureus, Escherichia 
coli and Salmonella sp. Pu et al. (2010) studied the antibacterial activity of 9-
octadecanoic acid-hexadecanoic acid-tetrahydrofuran-3,4-diyl ester from neem 
oil.  The minimum inhibitory concentration (MIC) and minimum bactericidal 
concentration (MBC) values of the 9-octadecanoic acid-hexadecanoic acid-
tetrahydrofuran-3,4-diyl ester were determined by using the broth microdilution 
(BMD) method at different concentrations ranging from 20 to 0.625 mg mL−1. The 
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antibacterial activity of 9-octadecanoic acid-hexadecanoic acid-tetrahydrofuran-3,4-
diyl ester against the three strains tested showed the relationship with time and 
concentration. 
1.2.1 (c) Antiviral 
In vitro antiviral property of neem against poliovirus was reported by Ligia (2012). 
Study aims at evaluating the activity of a polysaccharide (P1) such as water soluble 
pectic arabinogalactan isolated from the leaves of A. indica and their chemical 
sulfated derivatives (P1S) against poliovirus type 1 (PV-1). The cytotoxicity of the 
compounds was analyzed by MTT and the antiviral effect was determined by plaque 
reduction assay in different protocols. The polysaccharides did not show any 
cytotoxic effects on HepG2 cells at the highest tested concentration (200 μg/ml) and 
exhibited significant antiviral activity with inhibitory concentrations (IC₅₀) of 80 
μg/ml, 37.5 μg/ml, 77.5 μg/ml, and 12.1 μg/ml for P1, P1S and the selectivity indexes 
(SI) ranged from 18 to 131.9. Polysaccharide obtained from A. indica act against  
PV-1 by inhibiting the initial stage of viral replication. Importantly, original 
polysaccharides showed better virucidal effect than their sulfated derivatives at all 
tested concentrations. 
Badam, Joshi and Bedekar (1999) showed in vitro antiviral activity of neem extract 
against group B coxsackieviruses. Recent research in the defense research and 
development establishment, Gwalior showed that neem exhibits antiviral activity 
against dengue virus type-2 replication (Parida et al., 2002). Parida reported in vitro 
and in vivo inhibitory potential of crude aqueous extract of neem leaves and pure 
neem compound (Azadirachtin) on the replication of dengue virus type-2. In vitro 
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antiviral activity of aqueous neem leaves extract assessed in C(6/36) (cloned cells of 
larvae of Aedes albopictus) cells employing virus inhibition assay showed inhibition 
in dose dependent manner. 
1.2.1 (d) Antifungal 
Antimicrobial activity of neem oil was documented by Sairam et al. (2000). Efficacy 
of NIM-76, a spermicidal fraction from neem oil, was investigated for its 
antimicrobial action against certain bacteria, fungi and polio virus as compared to 
whole neem oil. The NIM-76 preparation showed stronger anti-microbial activity than 
the whole neem oil. NIM-76 also exhibited antifungal activity against Candida 
albicans and antiviral activity against polio virus replication in in vitro cell lines. It 
also protected mice from systemic candidiasis as revealed by enhanced percentage of 
survival and reduced colony forming units of C. albicans in various tissues. 
1.2.1 (e) Sexually transmitted disease 
A. indica activity against sexually transmitted diseases was studied by Kavita and 
Sanjay (2002). Research is in progress to identify plants and their active principles 
possessing activity against sexually transmitted pathogens including human 
immunodeficiency virus (HIV) with an objective of providing an effective approach 
for prevention of transmission and treatment of these diseases. Plants reported to 
possess activity or used in traditional systems of medicine for prevention and 
treatment of STDs including AIDS, herbal formulations for vaginal application, and 
topical microbicides from herbal origin have been documented. The effect of a neem 
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herbal formulation in treating abnormal vaginal discharge was studied by Sharma  
et al. (2009).  
Recent research by Shokeen, Bala and Tandon (2009) showed the activity of 16 
medicinal plants against Neisseria gonorrhoeae. 50% ethanolic extracts of various 
parts of 16 medicinal plants were evaluated for potential activity against clinical 
isolates and WHO strains of N. gonorrhoeae, including multi drug resistant (MDR) 
strains. Their activity was calculated as percentage inhibition in comparison with 
penicillin and ciprofloxacin and the strains were categorised as less sensitive, 
sensitive or highly sensitive to the extracts. The extracts caused differential inhibition 
of N. gonorrhoeae, with greater inhibition of the MDR strains. Among the extracts 
tested, 60% exhibited high activity whereas 20% showed moderate activity and 20% 
had little activity against N. gonorrhoeae. 
1.2.1 (f) Neem and the immune system 
Das et al. (2014) reported the effects on murine carcinoma expressing 
carcinoembryonic antigen like protein. Researchers generated a polyclonal antibody 
against a novel immunomodulator, neem leaf glycoprotein (NLGP) that can react to a 
specific 47 kDa subunit of NLGP. Generated antiNLGP antibody (primarily IgG2a) 
was tested for its antitumor activity in murine carcinoma (EC, CT-26), sarcoma 
(S180) and melanoma (B16Mel) tumor models. Tumor growth restriction was only 
observed in CT-26 carcinoma models, without any alteration in other tumor systems. 
Prevention of immune evasion and targeting of STAT3 phosphorylation by neem leaf 
glycoprotein was studied by Goswami et al. (2014). In this study, researchers 
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analyzed the in vitro immunomodulatory potential of a non-toxic neem leaf 
glycoprotein (NLGP) in reprogramming stage III M2TAMs induced by supraglottic 
laryngeal tumor cell lysate (SLTCL) to their classical antitumor shape (M1). Chief 
defensive macrophages are converted to immunosuppressive M2 type tumor 
associated macrophages (M2TAMs). M1 macrophages produce various cytotoxic 
mediators. Inflammatory macrophages in their classical form (M1) detect and destroy 
invading pathogens and exhibit direct cytotoxicity toward tumor cells in vitro. The 
study postulates a new mechanism of NLGP mediated tumor growth restriction in 
mice that reflects in better survivability of NLGP treated tumor hosts. 
Anti-tumor activity of neem leaf glycoprotein was reported by Mallick et al. (2013). 
Neem leaf glycoprotein is nontoxic to physiological functions of Swiss mice and 
Sprague Dawley rats. Neem leaf glycoprotein activates CD8+ T cells to promote 
therapeutic anti-tumor immunity inhibiting the growth of mouse sarcoma. 
Collectively, the outcome of the study support a paradigm in which NLGP 
dynamically orchestrates the activation, expansion, and recruitment of CD8+ T cells 
into established tumors to operate significant tumor cell lysis. 
Immunomodulatory and cancer preventive functions of neem leaf glycoprotein were 
reported by Baral et al. (2008). The invention provides a process for isolating and 
characterization of glycoprotein from neem leaf for immunomodulatory and cancer 
preventive functions of neem leaf glycoprotein (NLGP). The process includes the 
preparartion of crude neem leaf preparation (NLP) by soaking neem leaf powder in 
PBS for a period of 24 hours, extensive dialysis of crude NLP thus obtained against 
PBS, followed by subsequent concentration by membrane filtration, exposing NLGP 
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to temperature gradient of 0°C to 100°C, exposing the NLGP to different proteolytic 
enzymes and exposing the NLGP to various ions. 
Studies by Chakraborthy et al. (2008) neem leaf glycoprotein restore the impaired 
chemotactic activity of peripheral blood mononuclear cells from head and neck 
squamous cell carcinoma patients. Neem leaf glycoprotein is responsible for in vivo 
immunomodulation to restrict the growth of mice tumors. The effect of NLGP in the 
rectification of the dysregulated IFN gamma-dependent chemokine and its receptor 
CXCR3 splice variants was investigated. 
Chouhan et al. (2015) found that apoptosis mediated leishmanicidal activity of  
A. indica bioactive fractions is accompanied by Th1 immunostimulatory potential. 
Exploration of immunomodulatory antileishmanials of plant origin is now being 
strongly recommended to overcome the immune suppression evident during visceral 
leishmaniasis (VL) and the high cost and toxicity associated with conventional 
chemotherapeutics. In accordance, researchers assessed the in vitro and in vivo 
antileishmanial and immunomodulatory potential of ethanolic fractions of A. indica 
leaves and seeds. 
Alti et al. (2015) have also reported the in vitro and in vivo evaluation of 
antileishmanial and immunomodulatory activity of neem leaf extract in Leishmania 
donovani infection. The study is primarily focused to evaluate the anti-leishmanial 
effects of neem leaf extracts. Among which, ethyl acetate fraction (EAF) alone was 
found to exhibit leishmanicidal effect validated through cytotoxicity assay and 
estimated its IC to be 52.4µg/ml on the promastigote stage. 
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Immunomodulatory activity of an aqueous extract of the stem bark of A. indica was 
reported by Van der Nat et al. (1987). The interference of an aqueous extract of the 
stem bark of A. indica with different parts of the human immune system was 
investigated. The extract showed strong anticomplementary effects which were dose-
and time-dependent and most pronounced in the classical complement pathway assay. 
Moreover, a dose-dependent decrease in the chemiluminescence of 
polymorphonuclear leukocytes was observed and a dose-dependent increase in the 
production of migration inhibition factor by lymphocytes. 
Immunomodulatory effects of neem (A. indica) oil were reported by Upadhyay et al. 
(1992). The animals were treated intraperitoneally (i.p.) with neem oil, control 
animals received the emulsifying agent with or without peanut oil. Peritoneal lavage, 
collected on subsequent days, showed a maximum number of leukocytic cells on day 
3 following treatment with neem oil, peritoneal macrophages exhibited enhanced 
phagocytic activity and expression of MHC class-II antigens. 
Immunomodulatory effects of NIM-76, a volatile fraction from neem oil were 
reported by Sairam et al. (1997). Pre-treatment of rats with a single i.p. injection of 
NIM-76 resulted in an increase in polymorphonuclear (PMN) leukocytes with a 
concomitant decrease in lymphocyte counts. The immunomodulatory activity of NIM-
76 was found to be concentration-dependent. At 120 mg/kg body weight, there was an 
enhanced macrophage activity and lymphocyte proliferation response, while the 
humoral component of immunity was unaffected. The study indicates that NIM-76 
acts through cell-mediated mechanisms by activating macrophages and lymphocytes. 
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Prophylactic as well as therapeutic administration of neem leaf glycoprotein (NLGP) 
induces significant restriction of solid tumor growth in mice was reported 
by  Banerjee et al. (2014). Researchers investigated the effect of pretreatment of 
NLGP benefits regulation of tumor angiogenesis, an obligate factor for tumor 
progression. The study show that NLGP pretreatment results in vascular 
normalization in melanoma and carcinoma bearing mice along with downregulation 
of CD31, VEGF and VEGFR2. Accumulated evidences of the study suggested that 
NLGP regulated immunomodulation is active in tumor growth restriction and 
normalization of tumor angiogenesis as well, thereby, signifying its clinical 
translation. 
Sarkar et al. (2010) showed that neem leaf glycoprotein enhances carcinoembryonic 
antigen presentation of dendritic cells to T and B cells for induction of antitumor 
immunity by allowing generation of immune effector/memory response. Vaccination 
with neem leaf glycoprotein matured carcinoembryonic antigen (CEA) pulsed 
dendritic cells (DCs) enhances antigen-specific humoral and cellular immunity 
against CEA and restricts the growth of CEA(+) murine tumors. NLGP helps better 
CEA uptake, processing and presentation to T/B cells. 
1.2.1 (g) Anticarcinogenic activity 
Research (Ratna et al., 2010) showed identification of a cytotoxic activity of neem 
constituents. Ethanolic neem (A. indica) leaf extract induces apoptosis and reported 
by Perumal et al. (2012). Researchers investigated the molecular mechanisms 
involved in the induction of apoptosis and the antiproliferative activity exerted by 
ethanolic neem leaf extract (ENLE) on the human breast cancer cell lines. Two 
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different breast cancer cell lines such as estrogen dependent (MCF-7) and estrogen 
independent (MDA-MB-231) cells were exposed to various concentrations of 
ENLE. Results suggested that ENLE induced apoptosis and decreased cell 
proliferation through the inhibition of the IGF signalling molecules in both MCF-7 
and MDA MB-231 cells, which could be useful for breast cancer treatment. 
Antioxidant activity of neem leaves were documented by Manikandan et al. (2008). 
Researchers evaluated the chemopreventive potential of A. indica (neem) leaf 
fractions based on in vitro antioxidant assays, and in vivo inhibitory effects on  
7,12-dimethylbenzanthracene (DMBA) induced hamster buccal pouch (HBP) 
carcinogenesis. The results of this study suggest that the antioxidant properties of 
neem leaf fractions may be responsible for modulating key hallmark capabilities of 
cancer cells such as cell proliferation, angiogenesis and apoptosis in the HBP 
carcinogenesis model. 
Vinod et al. (2011) reported the mutagenic and antimutagenic activities of neem seed 
oil. Mutagenic and antimutagenic activity of neem oil (NO) and its DMSO extract 
were examined in the Ames Salmonella/microsome mutagenicity test and the mouse 
bone marrow micronucleus assay. Eight different strains of Salmonella typhimurium 
were used to study the genotoxicity of neem oil both in the presence and absence of 
Aroclor-1254 induced rat liver homogenate. Two-dose treatment protocol was 
employed to study the cytogenetic activity in micronucleus assay. Similarly, the 
antimutagenic activity of neem oil was studied against mitomycin (MMC) and 7,12-
dimethylbenz[a]anthracene (DMBA) in the above two test systems. Neem oil was 
nonmutagenic in all the eight tester strains of Salmonella typhimurium. In the study, 
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there was no significant increase in the frequency of micronucleated polychromatic 
erythrocytes (MNPCEs) in neem oil treated groups over the negative control (DMSO) 
group of animals, indicating the nonclastogenic activity of neem oil in the 
micronucleus test. Neem oil showed good antimutagenic activity against DMBA 
induced mutagenicity compared to its DMSO extract. These results indicate 
nonmutagenic activity of neem oil and significant antimutagenic activity of neem oil 
suggesting its pharmacological importance for the prevention of cancer. 
Trisha et al. (2004) studied the chemopreventive activity of A. indica leaf extract.The 
effect of two different doses (250 and 500 mg per kilogram body weight) of 80% 
ethanolic extract of the leaves of A. indica were examined on drug metabolizing 
Phase-I and Phase-II enzymes, antioxidant enzymes, glutathione content, lactate 
dehydrogenase, and lipid peroxidation in the liver of 7-week-old Swiss albino mice. 
Also anticarcinogenic potential of A. indica leaf extract was studied adopting protocol 
of benzopyrene-induced fore-stomach and 7,12-dimethyl benzanthracene (DMBA) 
induced skin papillomagenesis. There was a significant inhibition of tumor burden, in 
both the tumor model system studied (from P < 0.005 to P < 0.001). Tumor incidence 
was also reduced by both the doses of A. indica extract. 
1.2.1 (h) Antifertility  
The mechanism of action of neem oil was studied by Sharma et al. (1996). The study 
was undertaken to elucidate the mechanism of spermicidal action of NIM-76, a 
fraction isolated from neem oil. The spermicidal activity of NIM-76 was confirmed 
using a fluorescent staining technique. NIM-76 was found to affect the motility of the 
sperm in a dose-dependent manner. 
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Research in the 1990s by Charu and Shakti (1995) showed antifertility activity of 
neem. The effect of intrauterine neem treatment (IUNT) on ovarian functions and 
uterine responsiveness to ovarian hormones was examined in adult Wistar 
rats.  Treated animals had normal reproductive cycles as indicated by the vaginal 
smears; serum progesterone levels were also in the normal range. The study shows 
that the mode of antifertility action of IUNT is not because of uterine 
unresponsiveness to the ovarian hormones but due to impairment of embryo 
development.  
Early post implantation contraceptive effects of a purified fraction of neem (A. indica) 
seeds were reported by Mukherjee, Garg and Talwar (1999). The hexane extract of 
the neem seeds was found to be biologically active and was the precursor for the final 
active fraction. The active fraction, identified as a mixture of six components, could 
completely abrogate pregnancy in rodents up to a concentration of 10%. No apparent 
toxic effects could be seen following treatment with the fraction. The treatment with 
the active fraction caused a specific activation of T lymphocyte cells of CD8+ subtype 
as well as phagocytic cells followed by elevation in cytokines gamma-interferon and 
TNF. The results of the study show that a pure active fraction of neem seeds could be 
obtained for the purpose of early post implantation contraception when given orally, 
and its mechanism of action seems to be by activating cell mediated immune 
reactions. 
Anand, Tewari and Mathur (1988) documented the contraceptive action of neem oil in 
rodents. At subcutaneous doses up to 0.3 ml/rat, neem oil did not possess any 
estrogenic, antiestrogenic or progestational activity and appeared not to interfere with 
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the action of progesterone. These findings were confirmed using the histoarchitecture 
of the uterus of treated rats. Since the postcoital contraceptive effect of neem oil 
seems to be nonhormonal, neem oil would be expected to elicit fewer side effects than 
the steroidal contraceptives. 
1.2.1 (i) Skin diseases 
Neem has a remarkable effect on chronic skin conditions. A. indica is active against 
various skin disorders. Neem oil and leaves have been used for the treatment of skin 
disorders which was reported by Joseph (2008). Traditional medicines are used to 
treat various skin disorders such as psoriasis, eczema, alopecia, diabetic ulcer, warts, 
vitiligo, pemphigus, pompholyx and leprosy. 
1.2.1 (j) Antisnake venom activity  
Antisnake venom activity and mechanism of action of the active compound isolated 
from A. indica leaves was studied by Ashis et al. (2008). A compound [AIPLAI  
(A. indica PLA(2) inhibitor)] purified from the methanolic leaf extract of                   
A. indica inhibits the phospholipase A(2) enzymes in the cobra and Russell's viper 
venoms (RVVs) in a dose-dependent manner. Inhibition of catalytic and tested 
pharmacological properties of cobra venom (Naja naja and Naja kaouthia) PLA(2) 
enzymes by AIPLAI is significantly higher (P<0.05). The study shows that AIPLAI 
holds good promise for the development of novel antisnake venom drug in future. 
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1.2.1 (k) Circulatory disorders 
Cardioprotective effect of neem leaf extracts was documented by Peer et al. (2008). 
The study was designed to evaluate the cardioprotective potential of 
aqueous leaf extract of A. indica (AI) on the basis of haemodynamic, biochemical and 
histopathological parameters in isoprenaline induced myocardial infarction in rats and 
to compare with vitamin E, a known cardioprotective antioxidant. A. indica 
leaf extract exerts equipotent cardioprotective activity in the experimental model of 
isoprenalin induced myocardial necrosis in rats as compared to vitamin E, a known 
cardioprotective antioxidant. 
1.2.1 (l) Digestive disorders 
Hepatoprotective activity of A. indica leaves and bark extract was reported by 
Devmurari and Jivani (2010). In vitro studies involved isolation of hepatocytes and 
examination of the effect of toxicants along with the test samples. The rat hepatocytes 
were isolated by recirculating enzymatic perfusion technique (in situ). The lowering 
of enzyme level is a definite indication of hepatoprotective action of   A. indica. 
Cytoprotective and antisecretory effects of azadiradione were studied by Singh, et al. 
(2015). Researchers isolated azadiradione from the ethanolic extract of seeds of 
A. indica and evaluated for in vivo antiulcer activity in cold restraint induced gastric 
ulcer model, aspirin induced gastric ulcer model, alcohol induced gastric ulcers model 
and pyloric ligation induced ulcer model. Azadiradione exhibited potent antiulcer 
activity through the inhibition of H+ K+ATPase (proton pump) activity via its 
cytoprotective effect and also via its antisecretory effect. 
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Hepatoprotective activity of azadirachtin-A in carbon tetrachloride intoxicated Wistar 
rats was studied by Balignar et al. (2014). Hepatoprotective studies revealed that the 
CCl4 treatment group exhibited a decrease in total protein and albumin levels, 
whereas a significant increase in BUN, AST, ALT, and ALP levels were noticed 
compared with the vehicle treated control, indicating that there was liver damage 
caused by CCl4. Histology and ultrastructure study confirmed that pretreatment with 
azadirachtin-A dose-dependently reduced hepatocellular necrosis and, therefore, 
protected the liver against toxicity caused by CCl4. 
Antiulcer activity of A. indica bark was reported by Uday et al. (2002). The 
antisecretory and antiulcer effects of aqueous extract of Neem (A. indica) bark have 
been studied along with its mechanism of action, standardisation and safety 
evaluation. The extract can dose dependently inhibit pylorus ligation and drug 
induced (mercaptomethylimidazole) acid secretion with ED50 value of 2.7 and             
2 mg/ kg. respectively. Neem bark extract has therapeutic potential for the control of 
gastric hyperacidity and ulcer. 
Protective role of extracts of neem seeds in diabetes was studied by Gupta (2004). 
Effect of petroleum ether extracts of kernel (NSK) and husk (NSH) of neem 
(Azadirachta indica A. Juss, Meliaceae) seeds on the prevention of oxidative stress 
caused by streptozotocin (STZ) was investigated. Diabetes mellitus was induced in 
adult male Wistar rats after administration of STZ (55 mg/kg b.wt., i.p., tail 
vein). Results suggest that NSH and NSK prevent oxidative stress caused by STZ in 
heart and erythrocytes. However, no such preventive effect was observed on renal and 
hepatic toxicity. 
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1.2.1 (m) Nervous disorders 
The neuroprotective effect of A. indica leaf extracts in rats was studied by 
Sudhirkumar et al. (2005). In the study, bilateral common carotid artery (BCCA) 
occlusion for 30 min followed by 45 min reperfusion resulted in increase in lipid 
peroxidation, superoxide dismutase (SOD) activity and fall in total tissue sulfhydryl 
(T-SH) groups. A. indica pretreatment (500 mg/kg/day x 7 days) attenuated the 
reperfusion induced enhanced lipid peroxidation, SOD activity and prevented fall in 
T-SH groups. A. indica (500 mg/kg/day x 15 days) significantly reduced these 
hypoperfusion induced functional disturbances. Reactive changes in brain histology 
like gliosis, perivascular lymphocytic infiltration, recruitment of macrophages and 
cellular edema following long term hypoperfusion were also attenuated effectively by 
A. indica. The study provides an experimental evidence for possible neuroprotective 
potentiality of A. indica. 
1.2.1 (n) Parasitic diseases 
Inhibition of the growth and development of asexual and sexual stages of drug 
sensitive and resistant strains of the human malaria parasite Plasmodium 
falciparum by neem (A. indica) fractions was reported by Ravi et al. (1998).  In the 
study researchers systematically evaluated extracts of neem seeds and 
purified fractions further enriched in polar or non-polar constituents for their effect on 
in vitro growth and development of asexual and sexual stages of the human 
malaria parasite Plasmodium falciparum.  
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Lucantoni et al. (2006) showed the effects of a neem extract on blood feeding, 
oviposition and oocyte in Anopheles stephensi. In this study, a laboratory strain of 
Anopheles stephensi was used to assess the effects of a commercial formulation 
(Neem Azal), containing azadirachtin A at 34%, on blood feeding, oviposition and 
oocyte ultrastructure. Oral administration of neem azal to A. stephensi females 
through artificial blood meals did impair blood intake and oviposition in a 
concentration dependent manner. The study indicates that neem impairs hormone 
control of oogenesis and exerts a cytotoxic effect on both follicular cells and oocytes 
of the Asian malaria vector A. stephensi. 
1.2.2 Neem in animal health 
A. indica has been used in the studies of the treatment of a large number of diseases in 
animals ranging from systemic disorders to infections and was reported by Sudipta et 
al. (2010). In this study, researchers analyzed the pectic arabinogalactan isolated 
from A. indica and its chemically sulfated derivative. These macromolecules showed 
activity against bovine herpesvirus type-1. Their inhibitory concentration 50% values 
ranging from 31.12 to 105.25 μg/ml were lower than the cytotoxicity values (>1600–
1440 μg/ml). The anti-viral effect was exerted during virus adsorption to the cell. 
Anionic groups in particular the sulfate groups appeared to be very important for the 
anti-herpetic activity of these polymers. 
The A. indica bark is reported to be beneficial in cutaneous diseases. Antibacterial 
agent against fish bacteria was studied by Das et al. (1999). Aquaneem, an emulsified 
product prepared from the neem (A. indica) kernel was tested against four pathogenic 
bacteria of fish (Aeromonas hydrophila, Pseudomonas fluorescens, Escherichia coli 
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and Myxobacteria spp.) to test its efficacy as an antibacterial agent. Growth inhibitory 
property of the product at 10, 15 and 20 ppm has been noticed and recorded. Among 
all the bacteria tested A. hydrophila, P. fluorescens and Myxobacteria spp. exhibited 
maximum sensitivity to Aquaneem in terms of percentage reduction of bacterial cell 
population in comparison to E. coli. Yunxia et al. (2012) shows the acaricidal activity 
of petroleum ether extract of A. indica oil against Sarcoptes scabiei var. cuniculi in 
vitro. The acaricidal bioassay was conducted using a dipping method. The results 
indicated that the median lethal concentration (LC50) of the petroleum ether extract 
(at the concentration of 500.0ml/l) was 70.9ml/l, 24h after treatment. The results 
suggest that petroleum ether extracts of neem oil and its four fractions possess in vitro 
acaricidal activity. 
1.3 Neem tree 
1.3.1 Parts of neem 
The neem tree grows upto 30 m tall and has a girth of 2.5 m. It has straight trunk, 
which has a diameter of 30-80 cm (Mohammad, 2016). The branches of the neem tree 
spread across 20m. The leaves, bark, root and seeds of the neem trees have numerous 
medicinal properties for the treatment of many diseases. The leaves of the neem are 
bitter in taste. They are medium to dark in colour and 3-8 cm long. The flowers of the 
neem tree are white in colour. The inflorescence bear from 150-250 flowers and each 
flower is 5-6 mm long and 10 mm wide. The neem fruit is oval or round in shape. The 
skin of the fruit is very thin and called endocarp. Mesocarp is the pulp which if 
fibrous and bitter sweet to taste. The fruits are yellowish white in colour. The 
endocarp is the neem seed which is white in colour with a brown coating. The inner 
shell is very hard. 
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1.3.2 Chemical Constituents 
The neem compounds have been divided into two major categories such as 
isoprenoids and nonisoprenoids (Figure 1.2 – 1.22). The isoprenoids include 
diterpenoids and triterpenoids containing protomeliacins, limonoids, azadirone and its 
derivatives, gedunin and its derivatives, vilasinin type of compounds and 
csecomeliacins such as nimbin, salanin and azadirachtin (Morgan, 2009). Tetracyclic 
triterpenoids was isolated from the leaves of A. indica by Siddiqui et al. (2004). The 
nonisoprenoids include proteins (amino acids) and carbohydrates (polysaccharides), 
sulphurous compounds, polyphenolics such as flavonoids, flavonol glycosides, 
dihydrochalcone, coumarin, tannins and aliphatic compounds.  
1.3.2 (a) Isoprenoids – diterpenoids 
 
Figure 1.2 Sugiol  
       Molecular Formula: C20H28O2 
       Molecular Weight  : 300.442 
  
 
